Steven Libutti

Q: What Schools Are Affiliated With Steven Libutti

Steven Libutti is affiliated with the following schools: Columbia University, Yeshiva University, Harvard University, Rutgers University, University of Hong Kong, Rutgers University–Camden, Albert Einstein College of Medicine, University System of Maryland

Steven Libutti's AcademicInfluence.com Rankings

Steven Libutti

Philosophy

#10038

World Rank

#13718

Historical Rank

#1817

USA Rank

Logic

#6985

World Rank

#8576

Historical Rank

#991

USA Rank

philosophy Degrees

Download Badge

Philosophy

Why Is Steven Libutti Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Steven Kenneth Libutti, M.D., F.A.C.S. is an American surgeon and scientist. In January 2017, he became the third permanent Director of the Rutgers Cancer Institute of New Jersey, Vice Chancellor for Cancer Programs for Rutgers Biomedical and Health Sciences and the Senior Vice President for Oncology Services for RWJBarnabas Health, the largest health system in New Jersey. He is a tenured Distinguished Professor of Surgery at the Rutgers Robert Wood Johnson Medical School. Libutti's work on the study of tumor angiogenesis and the tumor microenvironment has led to novel approaches for the treatment of cancer. He is also one of the pioneers of regional and targeted cancer therapy.

(See a Problem?)

Steven Libutti's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Phase I and Pharmacokinetic Studies of CYT-6091, a Novel PEGylated Colloidal Gold-rhTNF Nanomedicine (2010) (540)
Somatic and germline CACNA1D calcium channel mutations in aldosterone-producing adenomas and primary aldosteronism (2013) (479)
Pulsed-High Intensity Focused Ultrasound and Low Temperature–Sensitive Liposomes for Enhanced Targeted Drug Delivery and Antitumor Effect (2007) (444)
A mouse model of multiple endocrine neoplasia, type 1, develops multiple endocrine tumors. (2001) (434)
Analysis of factors associated with outcome in patients with malignant peritoneal mesothelioma undergoing surgical debulking and intraperitoneal chemotherapy. (2003) (330)
MicroRNA dynamics in the stages of tumorigenesis correlate with hallmark capabilities of cancer. (2009) (273)
Clinical, genetic and radiographic analysis of 108 patients with von Hippel-Lindau disease (VHL) manifested by pancreatic neuroendocrine neoplasms (PNETs). (2007) (242)
Multiple neuroendocrine tumors of the pancreas in von Hippel-Lindau disease patients: histopathological and molecular genetic analysis. (1998) (242)
Gene expression profiles derived from fine needle aspiration correlate with response to systemic chemotherapy in breast cancer (2002) (227)
Forty-eight-hour fast: the diagnostic test for insulinoma. (2000) (211)
Pancreatic neuroendocrine tumors associated with von Hippel Lindau disease: diagnostic and management recommendations. (1998) (201)
Gene promoter methylation in prostate tumor-associated stromal cells. (2006) (186)
Characterization of a novel tumor-derived cytokine. Endothelial-monocyte activating polypeptide II. (1994) (179)
Induction of permeability across endothelial cell monolayers by tumor necrosis factor (TNF) occurs via a tissue factor-dependent mechanism: relationship between the procoagulant and permeability effects of TNF. (2002) (174)
Partial-Volume Correction in PET: Validation of an Iterative Postreconstruction Method with Phantom and Patient Data (2007) (173)
Advantages of mRNA amplification for microarray analysis. (2002) (167)
Vaccinia as a vector for tumor-directed gene therapy: Biodistribution of a thymidine kinase-deleted mutant (2000) (167)
The North American Neuroendocrine Tumor Society Consensus Paper on the Surgical Management of Pancreatic Neuroendocrine Tumors (2020) (160)
Treatment of Primary Peritoneal Mesothelioma by Continuous Hyperthermic Peritoneal Perfusion (CHPP) (1999) (158)
Comparison of noninvasive fluorescent and bioluminescent small animal optical imaging. (2003) (158)
Localization of insulinomas to regions of the pancreas by intraarterial calcium stimulation: the NIH experience. (2009) (157)
Laparoscopic cytoreductive nephrectomy as preparation for administration of systemic interleukin-2 in the treatment of metastatic renal cell carcinoma: a pilot study. (1999) (152)
Molecular Pathology of the MEN1 Gene (2004) (148)
Using gene expression profiling to differentiate benign versus malignant thyroid tumors. (2004) (143)
A phase I-II study of isolated hepatic perfusion using melphalan with or without tumor necrosis factor for patients with ocular melanoma metastatic to liver. (2000) (143)
Histopathology and molecular genetics of multiple cysts and microcystic (serous) adenomas of the pancreas in von Hippel-Lindau patients. (2000) (143)
Current Advances in Molecular Imaging: Noninvasive in Vivo Bioluminescent and Fluorescent Optical Imaging in Cancer Research (2003) (135)
Hyperparathyroidism in hereditary syndromes: special expressions and special managements. (2002) (133)
Prospective Study of Surgery for Primary Hyperparathyroidism (HPT) in Multiple Endocrine Neoplasia-Type 1 and Zollinger-Ellison Syndrome: Long-Term Outcome of a More Virulent Form of HPT (2008) (129)
Menin molecular interactions: insights into normal functions and tumorigenesis. (2005) (129)
Factors in Tissue Handling and Processing That Impact RNA Obtained From Formalin-fixed, Paraffin-embedded Tissue (2008) (128)
Hyperthermic isolated hepatic perfusion using melphalan for patients with ocular melanoma metastatic to liver. (2003) (128)
Antiangiogenic gene therapy of cancer utilizing a recombinant adenovirus to elevate systemic endostatin levels in mice. (2000) (128)
Kinetic analysis of the rapid intraoperative parathyroid hormone assay in patients during operation for hyperparathyroidism. (1999) (128)
Gene array analysis of macronodular adrenal hyperplasia confirms clinical heterogeneity and identifies several candidate genes as molecular mediators (2004) (123)
The angiogenesis inhibitor, endostatin, does not affect murine cutaneous wound healing. (2000) (122)
Serum endostatin levels are elevated and correlate with serum vascular endothelial growth factor levels in patients with stage IV clear cell renal cancer. (2000) (121)
Phase I study of heat-deployed liposomal doxorubicin during radiofrequency ablation for hepatic malignancies. (2012) (121)
Isolated hepatic perfusion for unresectable hepatic metastases from colorectal cancer. (2001) (115)
Parathyroid-specific double knockout of Gq and G11 alpha-subunits leads to a phenotype resembling germline knockout of the extracellular Ca2+ -sensing receptor. (2007) (113)
Treatment factors associated with long-term survival after cytoreductive surgery and regional chemotherapy for patients with malignant peritoneal mesothelioma. (2013) (113)
Phase I study of hepatic arterial melphalan infusion and hepatic venous hemofiltration using percutaneously placed catheters in patients with unresectable hepatic malignancies. (2005) (113)
Launching a Novel Preclinical Infrastructure: Comparative Oncology Trials Consortium Directed Therapeutic Targeting of TNFα to Cancer Vasculature (2009) (113)
Clinical and genetic analysis of patients with pancreatic neuroendocrine tumors associated with von Hippel-Lindau disease. (2000) (111)
Comparison of SUV and Patlak slope for monitoring of cancer therapy using serial PET scans (2002) (110)
Progress in antiangiogenic gene therapy of cancer (2000) (108)
Antiangiogenic gene therapy of cancer: recent developments (2004) (108)
Neuroendocrine tumors of the pancreas in von Hippel-Lindau disease: spectrum of appearances at CT and MR imaging with histopathologic comparison. (2002) (106)
Angiogenesis inhibitors target the endothelial cell cytoskeleton through altered regulation of heat shock protein 27 and cofilin. (2003) (105)
Intraarterial calcium stimulation and intraoperative ultrasonography in the localization and resection of insulinomas. (1997) (104)
Blind distal pancreatectomy for occult insulinoma, an inadvisable procedure. (2002) (103)
Insulinoma: pathophysiology, localization and management. (2010) (103)
Endothelial monocyte activating polypeptide II induces endothelial cell apoptosis and may inhibit tumor angiogenesis. (2000) (103)
Serum endostatin levels are elevated in patients with soft tissue sarcoma (2001) (102)
Parathyroid gland-specific deletion of the mouse Men1 gene results in parathyroid neoplasia and hypercalcemic hyperparathyroidism. (2003) (98)
Biomanufacturing for clinically advanced cell therapies (2018) (97)
Combining Agents that Target the Tumor Microenvironment Improves the Efficacy of Anticancer Therapy (2008) (97)
Noise reduction in oncology FDG PET images by iterative reconstruction: a quantitative assessment. (2001) (95)
A phase 2 study of radio frequency interstitial tissue ablation of localized renal tumors. (2000) (92)
Current advances in molecular imaging: noninvasive in vivo bioluminescent and fluorescent optical imaging in cancer research. (2003) (92)
Endostatin inhibits microvessel formation in the ex vivo rat aortic ring angiogenesis assay. (2000) (90)
Results of initial operation for hyperparathyroidism in patients with multiple endocrine neoplasia type 1. (2003) (87)
Retroviral gene transfer of interferon‐inducible protein 10 inhibits growth of human melanoma xenografts (2002) (85)
Management of Symptomatic Malignant Melanoma of the Gastrointestinal Tract (1999) (84)
Operative management for recurrent and metastatic adrenocortical carcinoma (2012) (82)
A Phase I trial of continuous hyperthermic peritoneal perfusion with tumor necrosis factor and cisplatin in the treatment of peritoneal carcinomatosis (1998) (81)
Identification of Genes Differentially Expressed in Benign versus Malignant Thyroid Tumors (2008) (80)
Oncolytic vaccinia virus expressing the human somatostatin receptor SSTR2: molecular imaging after systemic delivery using 111In-pentetreotide. (2004) (80)
Prospective analysis of circulating endostatin levels in patients with renal cell carcinoma (2002) (76)
Resection versus expectant management of small incidentally discovered nonfunctional pancreatic neuroendocrine tumors. (2016) (75)
Isolated limb reperfusion with tumor necrosis factor and melphalan in patients with extremity melanoma after failure of isolated limb perfusion with chemotherapeutics (1997) (75)
A subset of host B lymphocytes controls melanoma metastasis through a melanoma cell adhesion molecule/MUC18-dependent interaction: evidence from mice and humans. (2008) (73)
A Prospective Study of 2-[18F] Fluoro-2-Deoxy-D-Glucose/Positron Emission Tomography Scan, 99mTc-Labeled Arcitumomab (CEA-Scan), and Blind Second-Look Laparotomy for Detecting Colon Cancer Recurrence in Patients With Increasing Carcinoembryonic Antigen Levels (2001) (73)
Management and Outcome of Patients With Sporadic Gastrinoma Arising in the Duodenum (2003) (72)
Ultrasound and sestamibi scan as the only preoperative imaging tests in reoperation for parathyroid adenomas. (2000) (71)
Tumor vasculature‐targeted delivery of tumor necrosis factor‐α * (2009) (71)
Reoperation for hyperparathyroidism in multiple endocrine neoplasia type 1. (2001) (70)
A Prospective Analysis of Plasma Endostatin Levels in Colorectal Cancer Patients With Liver Metastases (2001) (68)
A Phase II Study of BEZ235 in Patients with Everolimus-resistant, Advanced Pancreatic Neuroendocrine Tumours. (2016) (68)
The tumour microenvironment: a novel target for cancer therapy. (2009) (67)
Evaluation and management of pancreatic lesions in patients with von Hippel–Lindau disease (2016) (67)
Deletion of the vitamin D receptor specifically in the parathyroid demonstrates a limited role for the receptor in parathyroid physiology. (2009) (65)
Consequences of adrenal venous sampling in primary hyperaldosteronism and predictors of unilateral adrenal disease. (2010) (65)
Recapitulation of pancreatic neuroendocrine tumors in human multiple endocrine neoplasia type I syndrome via Pdx1-directed inactivation of Men1. (2009) (65)
Radiofrequency Ablation of Cancer (2004) (65)
Results of heterotopic parathyroid autotransplantation: a 13-year experience. (1999) (64)
Insights into beta cell regeneration for diabetes via integration of molecular landscapes in human insulinomas (2017) (64)
Role of metastasectomy in the management of thyroid carcinoma: The NIH experience (2003) (63)
Operative management of islet-cell tumors arising in the head of the pancreas. (1998) (63)
Parametric images of blood flow in oncology PET studies using [15O]water. (2000) (61)
A prospective evaluation of laparoscopic exploration with intraoperative ultrasound as a technique for localizing sporadic insulinomas. (2005) (60)
Colloidal gold: a novel nanoparticle for targeted cancer therapeutics. (2010) (59)
The Functional Impact on Voice of Sternothyroid Muscle Division During Thyroidectomy (2008) (59)
Development of a clinical decision model for thyroid nodules (2009) (58)
Technique and results of hyperthermic isolated hepatic perfusion with tumor necrosis factor and melphalan for the treatment of unresectable hepatic malignancies. (2000) (57)
Molecular imaging of tumor angiogenesis (2002) (57)
In vivo sensitivity of human melanoma to tumor necrosis factor (TNF)-alpha is determined by tumor production of the novel cytokine endothelial-monocyte activating polypeptide II (EMAPII). (1999) (57)
Minimally Invasive Parathyroidectomy Versus Bilateral Neck Exploration for Primary Hyperparathyroidism. (2016) (57)
Current molecular diagnostics of breast cancer and the potential incorporation of microRNA (2009) (56)
Analysis of factors influencing outcome in patients with in-transit malignant melanoma undergoing isolated limb perfusion using modern treatment parameters. (2010) (56)
Cancer nanomedicines: closing the translational gap (2014) (55)
Liver Resection and Ablation for Metastatic Adrenocortical Carcinoma (2011) (55)
Rate of Clinically Significant Postoperative Pancreatic Fistula in Pancreatic Neuroendocrine Tumors (2012) (54)
What is the Best Criterion for the Interpretation of Adrenal Vein Sample Results in Patients with Primary Hyperaldosteronism? (2012) (52)
Operative management of Cushing syndrome secondary to micronodular adrenal hyperplasia. (2008) (52)
A six-gene model for differentiating benign from malignant thyroid tumors on the basis of gene expression. (2005) (51)
Endothelial monocyte-activating polypeptide II, a tumor-derived cytokine that plays an important role in inflammation, apoptosis, and angiogenesis. (2000) (51)
Measuring tumor blood flow with H(2)(15)O: practical considerations. (2000) (50)
Filamin A interacting protein 1‐like inhibits WNT signaling and MMP expression to suppress cancer cell invasion and metastasis (2014) (49)
Reoperation for parathyroid adenoma: a contemporary experience. (2009) (49)
Effect of retroviral endostatin gene transfer on subcutaneous and intraperitoneal growth of murine tumors. (2001) (49)
Tumor angiogenesis and endothelial cell modulatory factors. (1999) (48)
Tumour necrosis factor receptor I (p55) is upregulated on endothelial cells by exposure to the tumour-derived cytokine endothelial monocyte- activating polypeptide II (EMAP-II). (2000) (48)
Phase II Study of BEZ235 versus Everolimus in Patients with Mammalian Target of Rapamycin Inhibitor‐Naïve Advanced Pancreatic Neuroendocrine Tumors (2017) (48)
The utility of routine transcervical thymectomy for multiple endocrine neoplasia 1-related hyperparathyroidism. (2008) (48)
Role of tumor necrosis factor on toxicity and cytokine production after isolated hepatic perfusion. (2001) (47)
Inhibition of the mammary carcinoma angiogenic switch in C3(1)/SV40 transgenic mice by a mutated form of human endostatin (2002) (47)
Pharmacokinetics of Cisplatin Administered by Continuous Hyperthermic Peritoneal Perfusion (CHPP) to Patients with Peritoneal Carcinomatosis (1999) (47)
Simplified kinetic analysis of tumor 18F-FDG uptake: a dynamic approach. (2004) (46)
A Novel Nomogram for Peritoneal Mesothelioma Predicts Survival (2013) (46)
Isolated Hepatic Perfusion for the Treatment of Patients With Colorectal Cancer Liver Metastases After Irinotecan-Based Therapy (2005) (46)
Preoperative Thyroid Ultrasound Is Indicated in Patients Undergoing Parathyroidectomy for Primary Hyperparathyroidism (2011) (45)
General aspects of anti-angiogenesis and cancer therapy (2001) (44)
Using positron emission tomography 2-deoxy-2-[18F]fluoro-D-glucose, 11CO, and 15O-water for monitoring androgen independent prostate cancer. (2003) (43)
Results of a completed phase I clinical trial of CYT-6091: A pegylated colloidal gold-TNF nanomedicine. (2009) (43)
Factors Affecting Survival After Complete Response to Isolated Limb Perfusion in Patients With In-Transit Melanoma (2001) (43)
Early genetic mechanisms underlying the inhibitory effects of endostatin and fumagillin on human endothelial cells. (2004) (42)
Management of Extremity Recurrences After Complete Responses to Isolated Limb Perfusion in Patients With Melanoma (1999) (42)
Three-gene molecular diagnostic model for thyroid cancer. (2011) (41)
Proadrenomedullin NH2-Terminal 20 Peptide Is a Potent Angiogenic Factor, and Its Inhibition Results in Reduction of Tumor Growth (2004) (41)
Analysis of Factors Associated with Outcome in Patients Undergoing Isolated Hepatic Perfusion for Unresectable Liver Metastases from Colorectal Center (2009) (40)
Modulation of Tumor-host Interactions, Angiogenesis, and Tumor Growth by Tissue Inhibitor of Metalloproteinase 2 via a Novel Mechanism (2004) (40)
Association of VHL Genotype With Pancreatic Neuroendocrine Tumor Phenotype in Patients With von Hippel–Lindau Disease (2018) (40)
Noninvasive estimation of the aorta input function for measurement of tumor blood flow with [/sup 15/O] water (2001) (39)
A novel technique for quantifying changes in vascular density, endothelial cell proliferation and protein expression in response to modulators of angiogenesis using the chick chorioallantoic membrane (CAM) assay (2004) (39)
Preliminary results of laser tissue welding in extravesical reimplantation of the ureters. (1994) (38)
Skin closure with dye-enhanced laser welding and fibrinogen. (1991) (38)
Limited survival in patients with carcinomatosis from foregut malignancies after cytoreduction and continuous hyperthermic peritoneal perfusion (2005) (37)
Assessment of tumor growth in pancreatic neuroendocrine tumors in von Hippel Lindau syndrome. (2014) (37)
Multiple endocrine neoplasia type 1 deletion in pancreatic alpha-cells leads to development of insulinomas in mice. (2010) (37)
Pasireotide (SOM230) is effective for the treatment of pancreatic neuroendocrine tumors (PNETs) in a multiple endocrine neoplasia type 1 (MEN1) conditional knockout mouse model. (2012) (37)
Safety and enhanced immunostimulatory activity of the DRD2 antagonist ONC201 in advanced solid tumor patients with weekly oral administration (2019) (37)
Development and treatment of tertiary hyperparathyroidism in patients with pseudohypoparathyroidism type 1B. (2012) (36)
Isolated hepatic perfusion for the treatment of patients with advanced liver metastases from pancreatic and gastrointestinal neuroendocrine neoplasms. (2004) (36)
Tumor-associated endothelial cells display GSTP1 and RARβ2 promoter methylation in human prostate cancer (2006) (36)
AAVP displaying octreotide for ligand-directed therapeutic transgene delivery in neuroendocrine tumors of the pancreas (2016) (36)
Combination therapy targeting the tumor microenvironment is effective in a model of human ocular melanoma (2007) (36)
Persistent Primary Hyperparathyroidism Caused by Adenomas Identified in Pharyngeal or Adjacent Structures (2003) (36)
Treatment of patients with unresectable primary hepatic malignancies using hyperthermic isolated hepatic perfusion (2004) (35)
Parathyroid tumor development involves deregulation of homeobox genes. (2008) (35)
Hepatic vascular isolation and perfusion for patients with progressive unresectable liver metastases from colorectal carcinoma refractory to previous systemic and regional chemotherapy (2002) (34)
Functional characterization of filamin a interacting protein 1-like, a novel candidate for antivascular cancer therapy. (2008) (34)
Somatic VHL gene alterations in MEN2-associated medullary thyroid carcinoma (2006) (34)
Self-targeting of TNF-releasing cancer cells in preclinical models of primary and metastatic tumors (2016) (34)
Everolimus in Neuroendocrine Tumors of the Gastrointestinal Tract and Unknown Primary (2017) (33)
Deciphering von Hippel-Lindau (VHL/Vhl)-Associated Pancreatic Manifestations by Inactivating Vhl in Specific Pancreatic Cell Populations (2009) (33)
Surgical Oncologists and the COVID-19 Pandemic: Guiding Cancer Patients Effectively through Turbulence and Change (2020) (33)
Voice outcomes after total thyroidectomy, partial thyroidectomy, or non-neck surgery using a prospective multifactorial assessment. (2014) (33)
Activation of the phosphoinositide‐3‐kinase and mammalian target of rapamycin signaling pathways are associated with shortened survival in patients with malignant peritoneal mesothelioma (2011) (33)
A novel tumor-derived mediator that sensitizes cytokine-resistant tumors to tumor necrosis factor. (1996) (32)
Adenovirus-mediated endostatin delivery results in inhibition of mammary gland tumor growth in C3(1)/SV40 T-antigen transgenic mice. (2002) (32)
Prognostic value of initial fasting serum gastrin levels in patients with Zollinger-Ellison syndrome. (2001) (31)
Endothelial monocyte activating polypeptide-II induced gene expression changes in endothelial cells. (2005) (30)
Utility of rapid intraoperative parathyroid hormone assay to predict severe postoperative hypocalcemia after reoperation for hyperparathyroidism. (2002) (30)
Heterogeneous gland size in sporadic multiple gland parathyroid hyperplasia. (1999) (30)
Insulinomas and expression of an insulin splice variant (2004) (29)
32-Phosphorus selectively delivered by listeria to pancreatic cancer demonstrates a strong therapeutic effect (2017) (29)
Monitoring responses to antiangiogenic agents using noninvasive imaging tests. (1999) (29)
Liver Resection for Metastatic Melanoma with Postoperative Tumor-Infiltrating Lymphocyte Therapy (2009) (28)
Downregulation of Filamin A Interacting Protein 1-Like is Associated with Promoter Methylation and Induces an Invasive Phenotype in Ovarian Cancer (2011) (28)
Preoperative Localizing Studies for Initial Parathyroidectomy in MEN1 Syndrome: Is There Any Benefit? (2012) (27)
Loss of MEN1 activates DNMT1 implicating DNA hypermethylation as a driver of MEN1 tumorigenesis (2016) (27)
Understanding the role of gender in the incidence of thyroid cancer. (2005) (26)
Endothelial monocyte activating polypeptide-II modulates endothelial cell responses by degrading hypoxia-inducible factor-1alpha through interaction with PSMA7, a component of the proteasome. (2009) (26)
Analysis of factors associated with long-term (five or more years) cure in patients undergoing operation for Zollinger-Ellison syndrome. (1998) (26)
Utility of Intraoperative Parathyroid Hormone Monitoring in Patients with Multiple Endocrine Neoplasia Type 1-Associated Primary Hyperparathyroidism Undergoing Initial Parathyroidectomy (2013) (26)
Report from the society for biological therapy and vascular biology faculty of the NCI workshop on angiogenesis monitoring. (2004) (26)
Cancer development and progression. (2007) (25)
Microarray gene expression analysis of murine tumor heterogeneity defined by dynamic contrast-enhanced MRI. (2002) (25)
A Pilot Feasibility Study of TNFerade™ Biologic with Capecitabine and Radiation Therapy Followed by Surgical Resection for the Treatment of Rectal Cancer (2011) (25)
Canine choledochotomy closure with diode laser-activated fibrinogen solder. (1994) (24)
Noninvasive fluorescent imaging reliably estimates biomass in vivo. (2002) (23)
Targeting the invincible barrier for drug delivery in solid cancers: interstitial fluid pressure (2018) (23)
Intraperitoneal gemcitabine pharmacokinetics: a pilot and pharmacokinetic study in patients with advanced adenocarcinoma of the pancreas (2008) (22)
Sutureless rabbit bladder mucosa patch graft urethroplasty using diode laser and solder. (1995) (22)
Special techniques for imaging blood flow to tumors. (2002) (22)
Association of type-O blood with neuroendocrine tumors in multiple endocrine neoplasia type 1. (2013) (22)
Comparison of laser-assisted fibrinogen-bonded and sutured canine arteriovenous anastomoses. (1992) (22)
Targeting TNF-α for cancer therapy (2009) (21)
Glucose and insulin variations in patients during the time course of a FDG-PET study and implications for the "glucose-corrected" SUV. (2008) (21)
Design and proof of concept for targeted phage-based COVID-19 vaccination strategies with a streamlined cold-free supply chain (2021) (21)
Intentional resection of the diaphragm during cytoreductive laparoscopic radical nephrectomy. (2002) (21)
Laser welding with albumin‐based solder: Experimental full‐tubed skin graft urethroplasty (1996) (20)
National Cancer Institute Experience with Regional Therapy for Unresectable Primary and Metastatic Cancer of the Liver or Peritoneal Cavity (2000) (20)
Islet cell tumors. (2006) (20)
Development of a Method to Implement Whole-Genome Bisulfite Sequencing of cfDNA from Cancer Patients and a Mouse Tumor Model (2018) (20)
The role of thyroid resection during reoperation for persistent or recurrent hyperparathyroidism. (1997) (20)
Targeted AAVP-based therapy in a mouse model of human glioblastoma: a comparison of cytotoxic versus suicide gene delivery strategies (2019) (19)
Regulation of the pro‐angiogenic microenvironment by carboxyamido‐triazole (2003) (19)
Targeted radionuclide therapies for pancreatic cancer (2015) (18)
Ferumoxide-enhanced MRI in patients with colorectal cancer and rising CEA: surgical correlation in early recurrence. (2000) (18)
Comparison of 6-18F-fluoro-L-DOPA, 18F-2-deoxy-D-glucose, CT, and MRI in patients with pancreatic neuroendocrine neoplasms with von Hippel-Lindau disease. (2011) (18)
Pancreatic neuroendocrine tumors: entering a new era. (2012) (18)
Listeria delivers tetanus toxoid protein to pancreatic tumors and induces cancer cell death in mice (2022) (18)
Expression Signature Developed from a Complex Series of Mouse Models Accurately Predicts Human Breast Cancer Survival (2009) (17)
Laparoscopic resection of a nonparasitic liver cyst (1994) (17)
Management of asymptomatic, well-differentiated PNETs: results of the Delphi consensus process of the Americas Hepato-Pancreato-Biliary Association. (2019) (17)
Multiple endocrine neoplasia type 1: clinical manifestations and management. (2010) (17)
Amino acids-Rab1A-mTORC1 signaling controls whole-body glucose homeostasis (2021) (17)
Liposomal doxorubicin plus radiofrequency ablation for complete necrosis of a hepatocellular carcinoma. (2013) (17)
Dynamic Contrast-Enhanced Magnetic Resonance Imaging in the Assessment of Early Response to Tumor Necrosis Factor Alpha in a Colon Carcinoma Model (2006) (17)
Surgical management of multi-organ visceral tumors in patients with von Hippel-Lindau disease: a single stage approach. (2003) (16)
Association of Type O Blood with Pancreatic Neuroendocrine Tumors in Von Hippel–Lindau Syndrome (2012) (16)
Insulinoma and gastrinoma syndromes from a single intrapancreatic neuroendocrine tumor. (2008) (16)
The value of FDG‐PET in the staging of gastric adenocarcinoma: A single institution retrospective review (2016) (16)
Percutaneous radiofrequency ablation of hepatocellular carcinoma in the presence of portal vein thrombosis. (2003) (16)
Filamin A interacting protein 1-like as a therapeutic target in cancer (2014) (16)
von Hippel-Lindau disease-associated solid microcystic serous adenomas masquerading as pancreatic neuroendocrine neoplasms. (2012) (16)
Antiangiogenic therapy: targeting vascular endothelial growth factor and its receptors. (2003) (15)
Diagnosis and management of insulinoma: current best practice and ongoing developments (2015) (15)
Reduced expression of FILIP1L, a novel WNT pathway inhibitor, is associated with poor survival, progression and chemoresistance in ovarian cancer (2016) (15)
Impact of tumor resection (Rxn) and intraperitoneal (IP) chemotherapy (CHRx) on health related quality of life (HRQL) in patients (Pts) with peritoneal surface malignancies (PSM) (2004) (15)
Down-Regulation of Filamin Ainteracting protein 1-like Is Associated with Promoter Methylation and an Invasive Phenotype in Breast, Colon, Lung and Pancreatic Cancers (2013) (15)
Preliminary results of a phase I clinical trial of CYT-6091: A pegylated colloidal gold-TNF nanomedicine (2007) (15)
Improved antitumor response to isolated limb perfusion with tumor necrosis factor after upregulation of endothelial monocyte-activating polypeptide II in soft tissue sarcoma. (2002) (14)
Effects of diode laser welding with dye‐enhanced glue on tensile strength of sutures commonly used in urology (1996) (14)
Novel Dual-Action Targeted Nanomedicine in Mice With Metastatic Thyroid Cancer and Pancreatic Neuroendocrine Tumors (2018) (14)
Isolated Organ Perfusion Does Not Result in Systemic Microembolization of Tumor Cells (1999) (14)
Sutureless cataract incision closure using laser-activated tissue glues (1991) (14)
Obesity impairs wound healing in ovariectomized female mice. (2009) (14)
Interferon-&agr; Triggers Autoimmune Thyroid Diseases via Lysosomal-Dependent Degradation of Thyroglobulin (2018) (14)
Strategies for targeting tumors and tumor vasculature for cancer therapy. (2010) (13)
1992 Scientific Session of the Society of American Gastrointestinal Surgeons (SAGES) Washington, D.C., USA, April 11–12, 1992 (1992) (13)
Correlation between preoperative endoscopic ultrasound and surgical pathology staging of gastric adenocarcinoma: A single institution retrospective review (2016) (13)
Phase II studies of BEZ235 in patients with advanced pancreatic neuroendocrine tumors (pNET). (2015) (13)
Evolving paradigm for managing small nonfunctional incidentally discovered pancreatic neuroendocrine tumors. (2013) (13)
Successful outcome after surgical management in two cases of the "painful variant" of Hashimoto's thyroiditis. (2002) (13)
Gland Size Is Associated With Changes in Gene Expression Profiles in Sporadic Parathyroid Adenomas (2004) (13)
Gadolinium-enhanced 3D MRA prior to isolated hepatic perfusion for metastases. (1999) (12)
CC-5079: a small molecule with MKP1, antiangiogenic, and antitumor activity. (2010) (12)
Intermittent Hepatic Vein Balloon Occlusion During Radiofrequency Ablation in the Liver (2006) (12)
Mutations in CDKN2C (p18) and CDKN2D (p19) may cause sporadic parathyroid adenoma. (2013) (11)
Gastrinoma: sporadic and familial disease. (2006) (11)
Adrenal – Neuroendocrine Tumors (2017) (11)
A preliminary study of dye-enhanced laser photosclerosis. (1991) (11)
Cancer of the colon (2015) (11)
Endothelial monocyte activating polypeptide II (EMAP II) enhances the effect of TNF on tumor-associated vasculature. (2001) (10)
Sleeping parathyroid tumor: rapid hyperfunction after removal of the dominant tumor. (2012) (10)
Generation of mice encoding a conditional null allele of Gcm2 (2014) (10)
Correspondence re: Q-R. Chen et al., Liposomes complexed to plasmids encoding angiostatin and endostatin inhibit breast cancer in nude mice. Cancer Res., 59: 3308-3312, 1999. (2000) (10)
Updates in Pancreatic Neuroendocrine Carcinoma (2010) (10)
Canine colonic anastomoses reinforced with dye-enhanced fibrinogen and a diode laser (2004) (10)
Microarray Gene Expression Profiling of Angiogenesis Inhibitors Using the Rat Aortic Ring Assay (2002) (9)
Automated detection of blood vessels using dynamic programming (2003) (9)
Microarray technology and gene expression analysis for the study of angiogenesis (2002) (9)
Hypocalcemic stimulation and nonselective venous sampling for localizing parathyroid adenomas: work in progress. (1998) (9)
Correction: Down-Regulation of Filamin Ainteracting protein 1-like Is Associated with Promoter Methylation and an Invasive Phenotype in Breast, Colon, Lung and Pancreatic Cancers (2013) (9)
New horizons for cancer gene therapy (2014) (9)
Rapid measurement of insulin using the Abbott IMx: application to the management of insulinoma (2002) (9)
Recording 25 years of progress in Cancer Gene Therapy (2019) (9)
Laparoscopic applications of laser-activated tissue glues (1991) (8)
Surface-Modified Shortwave-Infrared-Emitting Nanophotonic Reporters for Gene-Therapy Applications. (2018) (8)
Improved antitumor response to isolated limb perfusion with tumor necrosis factor after upregulation of endothelial monocyte-activating polypeptide II in soft tissue sarcoma (2007) (8)
Novel agents in gastroenteropancreatic neuroendocrine tumors. (2013) (8)
Targeting Tumor Vasculature Using Adeno-Associated Virus Phage Vectors Coding Tumor Necrosis Factor-α (2014) (8)
Alternative wavelengths for sutureless laser microvascular anastomosis: a preliminary study on acute samples. (1992) (8)
B7 immune-checkpoints as targets for the treatment of neuroendocrine tumors. (2021) (8)
Comparison of laser-activated tissue solders and thrombin-activated cryoprecipitate for wound closure (1994) (7)
The effects of laser-assisted fibrinogen bonding on suture material. (1992) (7)
A randomized phase II trial comparing two doses of lenalidomide for the treatment of stage IV ocular melanoma. (2009) (7)
Phase I study of thermally sensitive liposomes containing doxorubicin (ThermoDox) given during radiofrequency ablation (RFA) in patients with unresectable hepatic malignancies (2007) (7)
Tracheal anastomosis using indocyanine green dye enhanced fibrinogen with a near-infrared diode laser (1990) (7)
Referral patterns for endocrine surgical disease. (2014) (7)
Juxtathyroidal neck soft tissue angiosarcoma presenting as an undifferentiated thyroid carcinoma. (2002) (7)
Reinforcement of high-risk anastomoses using laser-activated protein solders: a clinical study (1993) (7)
Design and proof-of-concept for targeted phage-based COVID-19 vaccination strategies with a streamlined cold-free supply chain (2021) (6)
Efficacy and safety of everolimus in advanced, progressive, nonfunctional neuroendocrine tumors (NET) of the gastrointestinal (GI) tract and unknown primary: A subgroup analysis of the phase III RADIANT-4 trial. (2016) (6)
Airway management during retrieval of the very large aspirated foreign body: a method for the flexible bronchoscope. (1995) (6)
Detection of blood vessels for radio-frequency ablation treatment planning (2001) (6)
In vivo proton MR spectroscopy of pancreatic neuroendocrine tumors in a multiple endocrine neoplasia type 1 conditional knockout mouse model (2015) (6)
Development of an aerosol intervention for COVID-19 disease: Tolerability of soluble ACE2 (APN01) administered via nebulizer (2022) (6)
Sensitivity of 3‐Dimensional Sonography in Preoperative Evaluation of Parathyroid Glands in Patients With Primary Hyperparathyroidism (2017) (6)
Management of Other Gastric and Duodenal Neuroendocrine Tumors. (2020) (6)
Microarray gene expression profiling of angiogenesis inhibitors using the rat aortic ring assay. (2002) (6)
Preliminary experience with laser reinforcement of vascular anastomoses (1991) (6)
Comparison of Bethesda cytopathology classification to surgical pathology across racial‐ethnic groups (2019) (6)
Development of a novel, pan-variant aerosol intervention for COVID-19 (2021) (6)
Skin closure with dye-enhanced laser welding and fibrinogen (1991) (6)
A phase II study of combretastatin A4-phosphate (CA4P) in the treatment of well-differentiated, low- to intermediate-grade, unresectable, recurrent, or metastatic pancreatic, or GI neuroendocrine tumors/carcinoid (GI-NETs/PNETs) with elevated biomarkers. (2017) (6)
Malignant Peritoneal Mesothelioma (2007) (5)
Do angiogenesis inhibitors perform a physiologic gatekeeper role in cancer prevention? (2004) (5)
Updates in pancreatic neuroendocrine carcinoma. Highlights from the "2010 ASCO Annual Meeting". Chicago, IL, USA. June 4-8, 2010. (2010) (5)
Tissue-specific induced DNA methyltransferase 1 (Dnmt1) in endocrine pancreas by RCAS-TVA-based somatic gene transfer system promotes β-cell proliferation (2018) (5)
Microarray Gene Expression Analysis of Murine Tumor Heterogeneity Defined by Dynamic Contrast-Enhanced MRI (2002) (5)
Genetically engineered lymphocytes and adoptive cell therapy: cancer immunotherapy’s smart bombs (2015) (5)
Highly versatile antibody binding assay for the detection of SARS-CoV-2 infection and vaccination (2021) (5)
Preliminary results of laser tissue welding in extravesical reimplantation of the ureters (1993) (4)
Cancer of the rectum (2018) (4)
Angiogenesis, Vascular Imaging, and Therapeutic Approaches in Ovarian Tumors (2001) (4)
Preliminary report: Laser welding and fibrinogen soldering are superior to sutured cholecyctostomy closure in a canine model (1990) (4)
Preliminary results with sutured colonic anastomoses reinforced with dye-enhanced fibrinogen and a diode laser (1991) (4)
SARS‐CoV‐2 nosocomial infection: Real‐world results of environmental surface testing from a large tertiary cancer center (2021) (4)
Apropos of Universal Epitope Discovery for COVID-19 Vaccines: A Framework for Targeted Phage Display-Based Delivery and Integration of New Evaluation Tools (2021) (4)
FILIP1L Loss Is a Driver of Aggressive Mucinous Colorectal Adenocarcinoma and Mediates Cytokinesis Defects through PFDN1 (2021) (4)
Future diagnostic and therapeutic trends in endocrine cancers. (2010) (4)
Aberrant methylation underlies insulin gene expression in human insulinoma (2020) (4)
Advances in understanding angiogenesis through molecular studies. (2006) (4)
The Cell Death Inhibitor ARC Is Induced in a Tissue-Specific Manner by Deletion of the Tumor Suppressor Gene Men1, but Not Required for Tumor Development and Growth (2015) (4)
Endocrine surgery specialty training: opportunities for growth. (2010) (4)
Highly versatile antibody binding assay for the detection of SARS-CoV-2 infection (2021) (4)
Imaging Features of Radiofrequency Ablation with Heat-Deployed Liposomal Doxorubicin in Hepatic Tumors (2016) (3)
Targeted therapies: Good news for advanced-stage pancreatic neuroendocrine tumors (2011) (3)
Laser bonding of secondary bronchi with solvent--detergent-treated cryoprecipitate. (1992) (3)
Force or stratagem? (2012) (3)
Peak stimulated insulin secretion is associated with specific changes in gene expression profiles in sporadic insulinomas. (2003) (3)
Therapy: Blockade of IGF-1R—not effective in neuroendocrine tumours (2013) (3)
Injection of bulking agents for laryngoplasty. (2018) (3)
1143PPH II STUDY OF BEZ235 IN PATIENTS WITH ADVANCED PANCREATIC NEUROENDOCRINE TUMORS (PNET) AFTER MTOR INHIBITOR THERAPY FAILURE: STAGE I INTERIM RESULTS. (2014) (3)
A PHASE II TRIAL TO EVALUATE RADIOFREQUENCY INTERSTITIAL TISSUE ABLATION (RITA) FOR THE TREATMENT OF RENAL CANCER (1999) (3)
Significance of preoperative radiographic pancreatic density in predicting pancreatic fistula after surgery for pancreatic neuroendocrine tumors. (2016) (3)
6621 POSTER Percutaneous Hepatic Perfusion (PHP) With Melphalan for Patients With Unresectable Liver Metastases of Neuroendocrine Tumours (MNET) – NCT00096083 (2011) (3)
Environmental Sars-Cov-2 Surface Testing: Low Incidence of Virus Positivity in Outpatient and Inpatient Hematology/Oncology Settings (2020) (2)
Surgical management of Cushing Syndrome secondary to micronodular adrenal hyperplasia (2008) (2)
A pilot study of local injection of TNFerade biologic in addition to neo-adjuvant chemoradiation for the treatment of primary and recurrent rectal cancer (2007) (2)
Analysis of toxicity and outcomes in patients undergoing hyperthermic isolated hepatic perfusion with melphalan for metastatic melanoma to the liver. (2013) (2)
Dye-Enhanced Tissue Welding Using Fibrinogen and Continuous-Wave Argon Lasers (1990) (2)
Laser-assisted solder closure of bronchial stumps (1992) (2)
STAT3: a crucial target for ovarian cancer stem cells that inhibits WNT signaling through a novel epigenetic mechanism (2017) (2)
Outcomes of Adrenalectomy and the Aldosteronoma Resolution Score in the Black and Hispanic Population (2021) (2)
Navigating the regulatory road to approval for cancer gene therapies (2015) (2)
Amino acids control blood glucose levels through mTOR signaling. (2022) (2)
Genetic strategies for targeting angiogenesis (2007) (2)
Menin Immunoreactivity in Secretory Granules of Human Pancreatic Islet Cells (2014) (2)
Parametric Images of Blood Flow in Oncology (2)
Thyroid Cancer: Molecular and Modern Advances (2011) (2)
Tumor-targeted delivery of childhood vaccine recall antigens by attenuated Listeria reduces pancreatic cancer (2019) (2)
Nesidioblastosis in Adults: A Clinical Enigmag (2001) (2)
A novel PDE4 inhibitory agent with endothelial cell specific activity. (2004) (2)
Prognostic and predictive biomarkers in gastroenteropancreatic neuroendocrine tumors. (2013) (2)
Safety and pharmacodynamics of the DRD2 antagonist ONC201 in advanced solid tumor patients with weekly oral administration. (2018) (2)
Abstract B076: Novel use of Listeria and gemcitabine to improve immunotherapy for pancreatic cancer (2016) (1)
Genetic and Structural Analysis of SARS-CoV-2 Spike Protein for Universal Epitope Selection (2022) (1)
Application of proteomic techniques to human tissues (2009) (1)
Evaluation of Adrenal Vein Sampling Use and Outcomes in Patients With Primary Aldosteronism. (2020) (1)
Outcomes Following Major Oncologic Operations for Non-AIDS-Defining Cancers in the HIV Population: A Matched Comparison to the General Population (2019) (1)
"Cures" Act Signed into Law. (2017) (1)
Regional Therapy of Cancer Using Continuous Hyperthermic Peritoneal Perfusion or Vascular Isolation and Perfusion Techniques (2004) (1)
Abstract No. 156: Clinical Trial for “Smart” Interventional Devices Using an Image Navigation Fusion System (2008) (1)
Abstract No. 194: Phase I Study of Heat Deployed Liposomal Doxorubicin During Thermal Ablation for Hepatic Malignancies (2009) (1)
Advances in Brief Adenovirus-mediated Endostatin Delivery Results in Inhibition of Mammary Gland Tumor Growth in C 3 ( 1 ) / SV 40 T-Antigen Transgenic Mice (2002) (1)
Early Results of a Pilot Study of Intra-tumoral Injection of TNFerade TM Biologic Concurrent With Neoadjuvant Chemoradiation Therapy for the Treatment of Primary and Recurrent Rectal Cancer (2007) (1)
Limited parathyroidectomy in multiple endocrine neoplasia type 1 associated primary hyperparathyroidism: a set up for failure (2014) (1)
A new immunotherapeutic concept for pancreatic cancer using childhood vaccine recall antigens and Listeria (2019) (1)
Humans Molecule / MUC 18-Dependent Interaction : Evidence from Mice Metastasis through a Melanoma Cell Adhesion A Subset of Host B Lymphocytes Controls Melanoma (2008) (1)
Abstract No. 109: Imaging Features in Patients Undergoing Liver RFA Plus Heat Deployed Nanoparticles (2008) (1)
Longitudinal Analysis of Biologic Correlates of COVID-19 Resolution: Case Report (2022) (1)
Phase I dose escalation and PK study of thermally sensitive liposomes containing doxorubicin given during radiofrequency ablation (RFA) in patients with non-resectable primary and metastatic liver cancer (2007) (1)
Novel agents in gastroenteropancreatic neuroendocrine tumors: Highlights from the "2013 ASCO gastrointestinal cancers symposium". San Francisco, CA, USA. january 24-26, 2013 (2013) (1)
Extracellular vesicle molecular signatures characterize metastatic dynamicity in ovarian cancer (2021) (1)
Preliminary results with dye-enhanced selective laser sclerosis of venous varicosities (1990) (1)
Of mice and men(in) and what I have learned from both. (2017) (1)
Targeted AAVP-based therapy in a mouse model of human glioblastoma: a comparison of cytotoxic versus suicide gene delivery strategies (2019) (0)
Abstract A61: Filamin A interacting protein 1-like inhibits WNT signaling and MMP expression to suppress ovarian cancer cell invasion and metastasis (2013) (0)
Effecy of isolated hepatic perfusion (IHP) in patients with progressive unresectable colorectal cancer (CRC) liver metastases (LM) after irinotecan (CPT-11) (2004) (0)
113 Prospective evaluation of qualtiy of life after tumor cytoreduction and intraperitoneal chemotherapy in patients with mesothelioma and other peritoneal surface malignancies (2006) (0)
217 - Comparison of Perioperative Chemotherapy vs. Postoperative Chemoradiation Therapy for Adenocarcinoma of the Gastric Cardia: An Analysis of the National Cancer Database (2018) (0)
Early-stage pancreatic neuroendocrine tumors (PNETs): Patience is a virtue. (2019) (0)
Abstract 3911: Bacteriophage associated silicon particles (BASP) for targeting pancreatic neuroendocrine tumors (2016) (0)
Soldering Is a Superior Alternative to Fibrin Sealant (2020) (0)
Reviewer recognition (2018) (0)
Gene Therapy Targeted at Angiogenesis and Lymphangiogenesis for Cancer Treatment (2007) (0)
ACTH-Producing Pancreatic Neuroendocrine Tumor Presenting with Severe Hypokalemic Alkalosis: A Case Report (2016) (0)
Extracellular Vesicle Molecular Signatures Characterize Metastatic Dynamicity in Ovarian Cancer (2021) (0)
Advances in the Diagnosis and Management of Nonfunctional Pancreatic Neuroendocrine Tumors (2020) (0)
IINovel Cytokine Endothelial-Monocyte Activating Polypeptide Is Determined by Tumor Production of the α Factor ( TNF )-Sensitivity of Human Melanoma to Tumor Necrosis In Vivo (2001) (0)
CHAPTER 56 – Antiangiogenesis (2003) (0)
Significance of pre-operative radiographic pancreatic density in predicting pancreatic fistula after surgery for pancreatic neuroendocrine tumors (2014) (0)
Clinical utility of endoscopic ultrasound in the pre-operative evaluation of gastric adenocarcinoma: a sonographic validation study (2014) (0)
Vitaxin™, a humanized monoclonal antibody recognizing αvβ3, does not inhibit healing in hamster or rabbit models of cutaneous wounds (2005) (0)
Editorial: Treatment decision making in the era of genetic testing and molecular diagnostics. (2017) (0)
Splenectomy Correlates With Worse Survival Independent of Disease Burden After Cytoreduction and Heated Intraperitoneal Chemotherapy for Malignant Peritoneal Mesothelioma (2013) (0)
Contents Vol. 79, 2010 (2011) (0)
Gland size is associated with changes in gene expression profiles in sporadic parathyroid adenomas (2006) (0)
Retroviral transduction of neoplastic murine hepatocytes with endostatin inhibits in vivo growth (2000) (0)
CHAPTER 26 – Antiangiogenic Gene Therapy (2002) (0)
Genome wide hypermethylated phenotype in VHL, SDHD, and SDHB associated pheochromcytomas (PCC). (2016) (0)
93rd annual convention podium and poster abstracts (1994) (0)
List of Contributors (2020) (0)
Abstract No. 313: Pasteurization of hepatic abscesses with RFA in immunocompromised patients with chronic granulomatous disease (2011) (0)
Subject Index Vol. 79, 2010 (2011) (0)
Compositions doc1 et méthodes de traitement du cancer (2008) (0)
SOFT TISSUE AND SKIN (2009) (0)
Abstract A184: Listeria-32P, a new approach to treat pancreatic cancer (2016) (0)
Analysis of factors influencing outcome in patients with in transit malignant melanoma (MM) undergoing isolated limb perfusion (ILP) using standardized operative parameters with melphalan and biological agents. (2006) (0)
Abstract B132: A new concept of cancer immunotherapy by targeting pancreatic ductal adenocarcinoma through a childhood recall antigen (2019) (0)
Research Report Advantages of mRNA Amplification for Microarray Analysis (2002) (0)
Prognostic V alue o f I nitial F asting S erum G astrin L evels in P atients W ith Z ollinger-Elliso n S yndrome (2001) (0)
Minimally Invasive Surgery for Pancreatic Neuroendocrine Tumors Results in Shorter Length of Stay (2018) (0)
Tissue-specific induced DNA methyltransferase 1 (Dnmt1) in endocrine pancreas by RCAS-TVA-based somatic gene transfer system promotes β-cell proliferation (2018) (0)
Can simplified kinetic Patlak analysis be used to monitor tumor therapy (2002) (0)
Clinical management of gastrinoma (2011) (0)
Cancer nanomedicines: Opportunities and challenges (2017) (0)
Composition to bond and seal tissue and method of using the same. (1991) (0)
QS442. An Analysis of Coagulation Profiles in Patients Undergoing Venous Hemofiltration After Intraarterial Chemotherapterapy for Unresectable Hepatic Malignancies (2008) (0)
Two novel DNMT1 inhibitors: 4'-Thio-2'-Deoxycytidine (TdCyd) and 5’-aza-4'-Thio-2'-Deoxycytidine (aza-TdCyd), for the treatment of MEN1 tumors in preclinical study (2020) (0)
Creating a new multidisciplinary cancer center using business architecture (2011) (0)
Abstract 3735: Somatostatin receptor-based imaging and treatment of murine pancreatic neuroendocrine tumors induced by MEN1-loss (2018) (0)
Reviewer Recognition (2019) (0)
Analysis o f F actors A ssociated W ith O utcome i n P atients W ith Malignant P eritoneal M esothelioma U ndergoing S urgical Debulking a nd I ntraperitoneal C hemotherapy (2003) (0)
von Hippel-Lindau disease-associated solid microcystic serous adenomas masquerading as pancreatic neuroendocrine tumors (2012) (0)
Debulking of Extensive Neuroendocrine Liver Metastases (2017) (0)
A randomized controlled trial to evaluate outcomes with Aggrenox in patients with SARS-CoV-2 infection (2023) (0)
Antiangiogenic Gene Delivery (2008) (0)
Association of Implementation of Operating Room-based Parathyroid Hormone Testing with Operative Time and Cost. (2022) (0)
Molecular signatures of eight thyroid tumor types (2006) (0)
Prognostic and predictive biomarkers in gastroenteropancreatic neuroendocrine tumors: Highlights from the "2013 ASCO gastrointestinal cancers symposium". San Francisco, CA, USA. january 24-26, 2013 (2013) (0)
Smoking-associated Downregulation of FILIP1L Enhances Lung Adenocarcinoma Progression Through Mucin Production, Inflammation, and Fibrosis (2022) (0)
A phase II study of sapanisertib (TAK-228) a mTORC1/2 inhibitor in rapalog-resistant advanced pancreatic neuroendocrine tumors (PNET): ECOG-ACRIN EA2161 (2022) (0)
Erratum: Gene expression for thyroid tumor classification (Cancer Research (April 15, 2004) 64, 1 (2898-2903)) (2004) (0)
Abstract No. 61: Technical Considerations in Hepatic Arterial Infusion of High Dose Melphalan with Hepatic Venous Hemofiltration (2008) (0)
Invited commentary. (2015) (0)
CDK4/6-MEK Targeted Therapy Causes Regression and Reduced Metastatic Colonization of Pancreatic Neuroendocrine Tumors (2023) (0)
Abstract 4718: Filamin A interacting protein 1-like is a marker of prognosis, progression and chemosensitivity in ovarian cancer (2017) (0)
Abstract 2080: Tissue-specific tumorigenesis in multiple endocrine neoplasia type I (2020) (0)
Abstract 1822: Antitumor activity of agents targeting the angiogenic factors angiopoietin-2 and thymidine phosphorylase in mouse models of lung and pancreatic neuroendocrine cancer (2017) (0)
Abstract No. 114: Percutaneous hepatic perfusion: Single institution review of technical considerations (2010) (0)
Isolated Hepatic Perfusion and Percutaneous Hepatic Perfusion (2009) (0)
Obesity and thyroid cancer. (2014) (0)
Impact of Implementation of Operating Room-Based Parathyroid Hormone Testing Reduces Operative Time and Cost (2021) (0)
Interferon-inducible protein (IP)-10 inhibition of melanoma xenograft growth in nude mice is associated with alterations in angiogenic gene expression profiles (2004) (0)
Tissue welding with virus-sterilized human cryoprecipitate (1992) (0)
Generation of mice encoding a conditional null allele of Gcm2 (2014) (0)
Abstract A4: Combretastatin A-4 Phosphate (CA4P) is effective for the treatment of functional pancreatic neuroendocrine tumors (PNETs) in a transgenic mouse model. (2013) (0)
MP50-20 INCREASED THYROID CANCER RISK IN PATIENTS WITH KIDNEY CANCERS (2015) (0)
Insights into beta cell regeneration for diabetes via integration of molecular landscapes in human insulinomas (2017) (0)
Role of Tumor Necrosis Factor on Toxicity and Cytokine Production after Isolated Hepatic Perfusion 1 (2001) (0)
Rare Adrenal Malignancy in a Patient With Acquired Immunodeficiency Syndrome and Epstein-Barr Virus (2015) (0)
Chapter-18 Surgery for MEN-1 Hyperparathyroidism (2017) (0)

This paper list is powered by the following services:

Other Resources About Steven Libutti

en.wikipedia.org

What Schools Are Affiliated With Steven Libutti?

Steven Libutti is affiliated with the following schools:

Steven Libutti's Academic­Influence.com Rankings